Overseas Profit Repatriation Supporters Include Schering-Plough, Lilly
This article was originally published in The Pink Sheet Daily
Executive Summary
Senate Minority Leader Daschle has yet to name conferees for the broader jobs bill, making it unlikely that any action on the legislation will be taken before the summer recess. Lilly has been the staunchest supporter of the repatriation provision for the pharma industry.
You may also be interested in...
“Repatriated” Funds Should Not Be Used For Rx Liability Costs – Congressman
House Ways & Means Health Subcommittee Ranking Member Stark (D-Calif.) urges the Treasury Department to prevent pharma companies such as Merck and Wyeth from using repatriated cash to cover legal expenses.
“Repatriated” Funds Should Not Be Used For Rx Liability Costs – Congressman
House Ways & Means Health Subcommittee Ranking Member Stark (D-Calif.) urges the Treasury Department to prevent pharma companies such as Merck and Wyeth from using repatriated cash to cover legal expenses.
Corporate "Tax Holiday" Nears President's Desk Following House Passage
The chamber approves a jobs bill containing a provision allowing U.S. companies to "repatriate" income claimed by overseas affiliates. The Senate is expected to consider the measure by Oct. 9.